Neoplasms, Endometrial Recruiting Phase 2 Trials for Pembrolizumab (DB09037)

Also known as: Endometrial Neoplasm / Endometrial Neoplasms / Endometrial neoplasia / Endometrial neoplasm NOS / Neoplasm endometrium / Neoplasm of endometrium

IndicationStatusPhase
DBCOND0034079 (Neoplasms, Endometrial)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03276013Pembrolizumab in Combination With Doxorubicin in Advanced, Recurrent or Metastatic Endometrial CancerTreatment